A phase 3b trial showed adjuvanted RSVPreF3 vaccination was immunogenic and safe for younger adults with chronic conditions ...
Regardless of 1 or 2 doses, mpox antibodies wane by 6 to 12 months. HealthDay News — Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; ...
Study shows that antibody levels stabilize across populations, offering a new lens for pandemic strategy and vaccine deployment. Study: Convergence of SARS-CoV-2 spike antibody levels to a population ...
COVID vaccination is no longer one-size-fits-all: US health officials now leave booster decisions to individuals, and the WHO urges “focused protection” for those at highest risk. Yet without hard ...
A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population. The work, published today as a Reviewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results